Skip to main content
All Posts
Skincare Science 11 min read

K-Beauty vs. European Skincare: The Regulatory Differences That Actually Affect What's in the Bottle

Nour Abochama
Nour Abochama

Host & Co-Founder

The number that stops most people cold: the European Union restricts or bans more than 1,300 cosmetic ingredients. The United States, until December 2022, had banned exactly eleven.

That’s not a typo. For 85 years — from the Federal Food, Drug, and Cosmetic Act of 1938 until the Modernization of Cosmetics Regulation Act — the US operated with a prohibited cosmetics list you could memorize in an afternoon. Meanwhile, American consumers were loading up on European serums and K-beauty essences, largely unaware that the products they were comparing were built under fundamentally different regulatory systems.

Understanding those differences won’t make you a cosmetic chemist. But it will make you a much smarter shopper — and help you ask the right questions about any product, wherever it’s made.

America’s Cosmetic Safety Rules — Finally Getting a Real Update

For most of its history, the FDA’s authority over cosmetics was strikingly limited. The agency could act after a product caused harm, but it couldn’t require manufacturers to prove a formula was safe before launch. No pre-market approval, no mandatory ingredient testing, no baseline requirement for facility inspections. A brand could formulate a new serum and put it on shelves tomorrow with essentially no federal gatekeeping.

That changed — partially — with MoCRA, signed into law on December 29, 2022. It’s the most significant overhaul of US cosmetic regulation in nearly a century, and it does expand FDA’s toolkit in real ways. Manufacturers must now register their facilities, maintain safety substantiation records, and report serious adverse events — including hospitalizations or life-threatening reactions tied to a product — within 15 days of receiving notice. The FDA also gained authority to order mandatory recalls, something it couldn’t do before.

But here’s the part that surprises most people: MoCRA still doesn’t require pre-market approval. A brand can formulate a new moisturizer and sell it without submitting anything to the FDA for review. The safety substantiation requirement is real, but it’s documentation kept internally — available during an FDA inspection, not reviewed before the product hits shelves.

So even in the MoCRA era, the regulatory floor in the US is lower than most consumers assume. The prohibited ingredient list has expanded somewhat, and FDA now has stronger enforcement tools. But the fundamental framework remains reactive: act when problems arise, not systematically before.

What the EU’s 1,300-Ingredient Ban List Actually Means in Practice

The EU Cosmetics Regulation — Regulation (EC) No 1223/2009 — operates on a different philosophy entirely: identify hazards, restrict or prohibit them upfront, and require a qualified safety assessor to sign off before any product reaches a consumer.

Annex II of the regulation lists substances completely prohibited in cosmetic products. That list covers categories like certain aromatic amines, heavy metal-based colorants, formaldehyde-releasing preservatives above defined concentration limits, and dozens of substances that failed the EU’s scientific safety review process. Annex III adds another layer — restricted substances that can only be used at defined concentrations for specified applications.

Beyond those prohibited and restricted lists, three critical ingredient categories operate on “positive lists.” Only preservatives that appear in Annex V are permitted. Only colorants listed in Annex IV. Only UV filters on Annex VI. If a UV filter isn’t on that approved list — regardless of its safety profile — it can’t legally be used in an EU sunscreen. This is exactly why several modern chemical UV filters widely used in Asian and European products (like Tinosorb S and Tinosorb M) still aren’t available in US sunscreens: not because they’ve been found dangerous, but because the American regulatory pathway for new sunscreen active ingredients has been functionally frozen since the 1990s.

Every EU cosmetic must also undergo a formal safety assessment by a qualified person — typically a trained toxicologist — before it can be placed on the market. That assessment is documented in a Product Information File, which EU market surveillance authorities can audit at any time. Animal testing for finished cosmetics was banned across the EU in 2004, and for cosmetic ingredients in 2013, pushing manufacturers toward alternative testing methods years before the US started seriously considering similar requirements.

Does all this mean EU products are flawless? No — post-market surveillance still catches problems, and the Scientific Committee on Consumer Safety (SCCS) regularly reassesses ingredients as new data emerges. But the baseline of what gets evaluated before a product is sold is meaningfully more rigorous than what US law has historically demanded.

South Korea’s MFDS: Stricter on Efficacy Claims, More Flexible on Standard Formulas

South Korea’s Ministry of Food and Drug Safety (MFDS) regulates cosmetics under the Cosmetics Act, and it has a structural distinction that exists in neither the US nor the EU: a formal two-tier system separating ordinary cosmetics from “functional cosmetics” (기능성화장품).

Standard K-beauty products — toners, essences, cleansers, sheet masks, ampoules — fall under ordinary cosmetic regulation. The rules include prohibited ingredient lists and quality standards, but there’s no mandatory pre-market safety assessment comparable to the EU’s required toxicologist sign-off. In this respect, standard K-beauty operates closer to the pre-MoCRA US framework than the EU’s stricter pre-market model.

Functional cosmetics are a different story entirely. MFDS designates specific claim categories that trigger heightened scrutiny: skin whitening and brightening, wrinkle reduction, UV protection, hair loss prevention, and self-tanning, among others. To sell a product making these claims in South Korea, brands must either submit efficacy and safety data to MFDS for review, or use pre-approved ingredient combinations at specified concentrations. This means K-beauty brightening serums and anti-aging creams that carry specific functional claims actually have more documented efficacy substantiation behind them than most equivalent US products do.

For the hero ingredients that made K-beauty famous globally — galactomyces ferment filtrate, snail secretion filtrate, centella asiatica extracts — the picture is simpler. These are ordinary cosmetic ingredients in South Korea, not functional claims, so they don’t trigger the stricter pathway. Their safety track record is documented in MFDS ingredient databases, and their widespread, decades-long use in the Korean market is meaningful real-world evidence. But specific performance claims around them would require the functional cosmetics route.

One thing that genuinely distinguishes reputable Korean manufacturers: widespread voluntary adoption of GMP (Good Manufacturing Practices) certification. Brands producing for export to EU and US markets typically operate certified facilities, and Korean GMP standards are internationally recognized. That’s brand-level diligence, though — not a universal regulatory baseline every K-beauty product meets automatically.

What This Means When You’re Actually Shopping

None of this is an argument for or against any particular skincare origin. European products aren’t automatically superior, and K-beauty or American brands aren’t inherently riskier. But the regulatory context does change how you should read what you’re buying.

For European products, you can reasonably expect that a pre-market safety assessment was completed, that a broad set of hazardous substances was screened out through Annex II and III, and that manufacturing met defined standards. The EU framework covers safety, not performance — so a product passing EU requirements doesn’t mean it works, just that a qualified person reviewed the formula before launch. That’s still meaningful assurance.

For K-beauty, the answer depends on what the product claims to do. Functional cosmetics — anything making whitening, anti-aging, or SPF claims — carry efficacy substantiation that ordinary cosmetics in any country don’t require. Standard K-beauty products are regulated for safety, but without the EU’s pre-market safety assessment requirement. Quality varies considerably by brand, and compelling marketing doesn’t imply MFDS review.

For US products, the MoCRA era is genuinely different from 2021 — facility registration, adverse event reporting, and mandatory recall authority all matter. But the core gap between the US and EU frameworks remains: no pre-market approval, no mandatory independent safety assessment. Brands that go further voluntarily — third-party testing, NSF International certification, ISO 22716 GMP audits, published lab results — are making choices above the regulatory floor, not just meeting a requirement.

Across all three markets, regulatory origin is an imperfect proxy for quality. Products from every region have passed regulatory requirements and later been found, through independent testing, to contain contaminants or mislabeled ingredients. What predicts quality more reliably than country of origin: whether the brand works with accredited independent labs and makes that testing data available. That transparency — not the flag on a shipping box — is what actually tells you something useful.

Regulatory frameworks create floors. The best brands build well above them. Knowing the floor each region sets, and knowing to ask what a brand has done beyond the minimum, is the most actionable thing any skincare consumer can take into a purchase decision in 2026.


Written by Nour Abochama, Host & Quality Control Expert, Nourify & Beautify. Learn more about our team

Have questions about product safety? Talk to our experts. Contact us

Nour Abochama
Written by
Nour Abochama

Host & Co-Founder · Quality Control Expert in Supplements, Cosmetics & Pharmaceuticals

Nour Abochama is a quality control expert in supplements, cosmetics, and pharmaceuticals, and co-founder of Labophine Garmin Laboratories and American Testing Lab. She bridges the gap between manufacturers and consumers through transparent, science-backed conversations.

Want more expert insights?

New episodes every week — subscribe free on YouTube or Podbean.